The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Gill, Richdeep S ^a   Perry, Troy ^a   Abele, Jonathan T ^a   Bédard, Eric L R ^a   Schiller, Daniel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenoma; Colon cancer; Incidental intraabdominal findings; Lung cancer; PET scan; Pulmonary nodules

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON; COLON ADENOCARCINOMA; COLON ADENOMA; DRUG UPTAKE; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; INSULINOMA; LIPOMA; LUNG CANCER; LUNG NODULE; MALE; MEDICAL RECORD REVIEW; PANCREATICODUODENECTOMY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; ADENOCARCINOMA; ADENOMA; CANCER STAGING; FOLLOW UP; INCIDENTAL FINDING; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PATHOLOGY; SCINTISCANNING; SURVIVAL RATE;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84856181065     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-25     Document Type: Article

References (17)

1. Marom EM, Bruzzi JF, Truong MT. Extrathoracic PET/CT findings in thoracic malignancies. J Thorac Imaging 2006, 21:154-166. 10.1097/00005382-200605000-00007, 16770232.
2. Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J 2001, 17:802-820. 10.1183/09031936.01.17408020, 11401078.
3. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, Siegel BA, Rusch VW. Results of the American college of surgeons oncology group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003, 126:1943-1951. 10.1016/j.jtcvs.2003.07.030, 14688710.
4. Nolop KB, Rhodes CG, Brudin LH, Beaney RP, Krausz T, Jones T, Hughes JM. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987, 60:2682-2689. 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H, 3499969.
5. Ido T, Wan C, Carella V, Fowler JS, Wolf AP, Reivich M, Kuhl DE. Labeled 2-deoxy-D-glucose analogs: 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose. J Label Compds Radiopharm 1978, 24:174-83.
6. Pauwels EK, McCready VR, Stoot JH, van Deurzen DF. The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 1998, 25:277-305. 10.1007/s002590050229, 9580862.
7. Yasuda S, Ide M, Takagi S, Shohtsu A. Elevated F-18 FDG uptake in skeletal muscle. Clin Nucl Med 1998, 23:111-112. 10.1097/00003072-199802000-00014, 9481504.
8. Yasuda S, Fujii H, Takahashi W, Takagi S, Ide M, Shohtsu A. Elevated F-18 FDG uptake in the psoas muscle. Clin Nucl Med 1998, 23:716-717. 10.1097/00003072-199810000-00023, 9790059.
9. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001, 10:725-731.
10. Yasuda S, Ide M, Takagi S, Shohtsu A. F-18 FDG uptake in colonic adenoma. Clin Nucl Med 1998, 23:99-100. 10.1097/00003072-199802000-00008, 9481498.
11. Zhuang H, Hickeson M, Chacko TK, Duarte PS, Nakhoda KZ, Feng Q, Alavi A. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 2002, 27:628-632. 10.1097/00003072-200209000-00004, 12192279.
12. Beatty JS, Williams HT, Aldridge BA, Hughes MP, Vasudeva VS, Gucwa AL, David GS, Lind DS, Kruse EJ, McLoughlin JM. Incidental PET/CT findings in the cancer patient: How should they be managed?. Surgery 2009, 146:274-281. 10.1016/j.surg.2009.04.024, 19628085.
13. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings. Radiology 1998, 206:755-760.
14. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology. Cancer 2010, 116:1454-1461. 10.1002/cncr.24885, 20143447.
15. Patel SA, Zenilman ME. Outcomes in older people undergoing operative intervention for colorectal cancer. J Am Geriatr Soc 2001, 49:1561-1564. 10.1046/j.1532-5415.2001.4911254.x, 11890600.
16. Lee ST, Tan T, Poon AMT, Toh HB, Gill S, Berlangieri SU, Kraft E, Byrne AJ, Pathmaraj K, O'Keefe GJ, Tebbutt N, Scott AM. Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluro-D-glucose-avid colon lesions. Mol Imaging Biol 2008, 10:48-53. 10.1007/s11307-007-0117-0, 17994266.
17. Agress H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: Histopathologic comparison. Radiology 2004, 230:417-422. 10.1148/radiol.2302021685, 14699176.